Treatment Category | N (%) Number of Beneficiaries | Mean (SD) SMBG Test Strips Claimed* | Mean (SD) Government Contribution Through the NSSPP+ (Can $) | Mean (SD) Beneficiary Contribution Through Copayment and MAC policy+ (Can $) | Mean (SD) Total Cost+ (Can$) |
---|---|---|---|---|---|
Insulin products only | 1786 (13.2) | 2.0 (1.5) | 562.17 (414.52) | 52.34 (43.58) | 614.50 (441.31) |
Oral antihyperglycemic agents only | 7252 (53.5) | 1.0 (0.9) | 271.61 (241.59) | 39.90 (38.18) | 311.51 (262.97) |
Insulin products + Oral antihyperglycemic agents | 1006 (7.4) | 2.0 (1.3) | 546.94 (361.59) | 46.26 (38.90) | 593.20 (382.50) |
No reimbursed diabetes medications | 3520 (25.9) | 0.7 (0.6) | 182.13 (177.88) | 36.75 (34.84) | 218.89 (197.77) |